Cellebrite DI Ltd.

NasdaqGS:CLBT Stock Report

Market Cap: US$4.8b

Cellebrite DI Past Earnings Performance

Past criteria checks 0/6

Cellebrite DI's earnings have been declining at an average annual rate of -53.2%, while the Software industry saw earnings growing at 19.9% annually. Revenues have been growing at an average rate of 15.8% per year.

Key information

-53.2%

Earnings growth rate

-49.5%

EPS growth rate

Software Industry Growth17.3%
Revenue growth rate15.8%
Return on equity-106.2%
Net Margin-82.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Cellebrite: There Are Potential Risks That Could Damper Growth

Nov 08

Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

Oct 30
Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Sep 10
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Cellebrite: Rating Downgrade As Valuation Has Caught Up

Aug 27

Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Aug 17
Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Jun 25
Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

May 21
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

Cellebrite: Big Fish In A Small Pond

Apr 29

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Revenue & Expenses Breakdown

How Cellebrite DI makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqGS:CLBT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24385-31717595
30 Jun 24362-10316689
31 Mar 24343-11216186
31 Dec 23325-8115484
30 Sep 23306-6414582
30 Jun 23294-4214584
31 Mar 232802014282
31 Dec 2227111613881
30 Sep 2226516513880
30 Jun 2225915214275
31 Mar 2225512213270
31 Dec 212467012466
30 Sep 21236711861
30 Jun 2122379858
31 Mar 2120929656
31 Dec 20195-99254
31 Dec 19172-109147

Quality Earnings: CLBT is currently unprofitable.

Growing Profit Margin: CLBT is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CLBT is unprofitable, and losses have increased over the past 5 years at a rate of 53.2% per year.

Accelerating Growth: Unable to compare CLBT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CLBT is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (27.6%).

Return on Equity

High ROE: CLBT has a negative Return on Equity (-106.24%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 07:14
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cellebrite DI Ltd. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tal LianiBofA Global Research
Tomer ZilbermanBofA Global Research
Tyler RadkeCitigroup Inc